Therapies, Treatments, and Procedures

Page 2 of 512345

April 29, 2014

Experimental Therapies for CSR

Posted in: Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts April 2014 Updated September 8, 2015 Research has shown that corticosteroids produced by the body (endogenous) and administered externally (exogenous) can raise adrenaline levels, which can harm the central retina. Some people have high levels of endogenous steroids that can lead to a condition called central serous retinopathy (CSR), aka central serous
read more »

January 29, 2014

U-M Kellogg Eye Center performs first two retinal prosthesis implants in U.S. since FDA approval

Posted in: Latest News, Therapies, Treatments, and Procedures

Kellogg retina surgeons implant Argus II Retinal Prosthesis, or ‘bionic eye,’ for two patients with end-stage retinitis pigmentosa ANN ARBOR, Mich. — Retina surgeons at the University of Michigan Kellogg Eye Center have performed the first – and second – surgeries in the United States to implant an artificial retina, or “bionic eye,” since the U.S. Food and
read more »

December 11, 2013

Time Between Lucentis and Eylea Treatments Found To Be Similar

Posted in: Latest News, Therapies, Treatments, and Procedures

The principal difference between the two leading FDA-approved anti-VEGF drugs, Eylea and Lucentis for treatment of retinal hemorrhage has been accepted as the difference in length of time between injections. A new study, however, found no significant difference in injection scheduling between the drugs. The overall mean days between injections differed by only 1.8 days
read more »

October 3, 2013

New Drug Effective in Treating Vitreous Traction

Posted in: Latest News, Therapies, Treatments, and Procedures

Early treatment with a new drug called JETREA® (formerly called ocriplasmin) has shown effectiveness in lessening the risk of macular pucker, macular hole, and vitreomacular traction (VMT). These conditions are caused by the tugging on the macula by the vitreous gel, which is attached to the retina at several points. As the vitreous shrinks with
read more »

September 24, 2013

Non-Mydriatic Retinal Cameras Offer Safer Examination

Posted in: Latest News, Therapies, Treatments, and Procedures

by Liz Trauernicht, Director MD Foundation A significant amount of evidence finds that very bright light, especially blue light, can damage the macula. Traditional slit lamp devices used during eye exams produce high light levels, which may be problematic for people with macular degeneration. Before these devices can be used effectively, the pupil of the
read more »

August 29, 2013

“As-Needed” Injections Are an Option for Wet AMD

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

Two-year results from the recently-completed HARBOR trial showed that some patients with wet AMD fare as well from Lucentis (ranibizumab) injections on an as-needed basis compared to a monthly basis. The original Lucentis trial recommended monthly dosing until the eye stabilized. The follow-up study, however, found that 93% of patients responded well with an average
read more »

August 19, 2013

Medicare Approves Payment for Argus® II Retinal Prosthesis System

Posted in: Latest News, Therapies, Treatments, and Procedures

Payments Will Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings  Sylmar, CA- August 15, 2013—Second Sight Medical Products, Inc. today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) beginning October 1, 2013.  These payments are designed to support
read more »

July 20, 2013

Gene Therapy Without Retinal Risk

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University
read more »

July 6, 2013

What Should I Ask My Doctor?

Posted in: Daily Living, Eye Conditions, Health and Nutrition, Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts Updated July 2013 One of the most common problems encountered by people who are first diagnosed with macular degeneration is what to ask the doctor. The news usually takes us by surprise, and we may have never even heard of the disease before. To compound our confusion, many doctors do not have
read more »

July 6, 2013

Preferential Hyperacuity Perimetry (PHP)

Posted in: Therapies, Treatments, and Procedures

A Method of Early Detection of AMD Progression by Dan Roberts Carl Zeiss Meditec, Inc. has developed a device that is proving to be an effective tool for early detection of age-related macular degeneration (AMD). Called the PreView PHP™ (Preferential Hyperacuity Perimetry), it identifies deviations in the retina using a vision test based upon the
read more »

Page 2 of 512345

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann